致敬每一位攻坚克难的项目伙伴！

继巴西登记成功落地后，江西众和生物再拓新版图，澳大利亚APVMA登记证正式获批！

从南美到大洋洲，连续拿下海外登记，标志着公司国际化布局持续突破，全球合规实力稳步夯实。

深耕农化原药研发与规模化生产，核心产品涵盖：丁噻隆（Tebuthiuron）、环磺酮（Tembotrione）、甲磺草胺（Sulfentrazone）、氟噻草胺（Flufenacet）、苯唑草酮（Topramezone）等多款优势原药。

一纸登记，一份认可。衷心感谢长久以来信任、支持我们的每一位客户与合作伙伴。

未来，众和将持续深耕全球市场，以稳定品质与完善合规体系，为全球客户创造更高价值。

—— Jiangxi Zhonghe Biotechnology Co., Ltd.   👏 Another Major Milestone Achieved!

Following the successful registration in Brazil, Jiangxi Zhonghe Biotechnology Co., Ltd. has achieved another important milestone in its global expansion — our APVMA registration in Australia has been officially approved!

From South America to Oceania, these consecutive overseas registration approvals mark another step forward in Zhonghe’s journey toward the global crop protection market, further strengthening our international regulatory capabilities and market presence.

We would like to express our sincere gratitude to all team members and partners who contributed to this achievement through their dedication, professionalism, and continued support.

For Zhonghe, every registration is more than a certificate — it represents recognition, trust, and another step toward the world.

With a strong focus on the R&D and large-scale production of agrochemical technical materials, Zhonghe offers a diversified portfolio of key active ingredients, including Tebuthiuron, Tembotrione, Sulfentrazone, Flufenacet, Topramezone, and other crop protection products.

Supported by our integrated supply chain, advanced manufacturing capabilities, and continuous investment in global registrations, Zhonghe is steadily expanding its presence in international agricultural markets.

From Jiangxi, China, to Brazil, Australia, and onward to the world.

Our mission remains unchanged:

To become a trusted partner for customers and growers worldwide.

Zhonghe for Harvest, Hope for Growth.